Alnylam Pharmaceuticals, Carvana and MongoDB among US research changes
CVNA•Analysts revised ratings and price targets for several U.S.-listed companies. Oppenheimer adjusted Carvana’s target to $90 from $450 to reflect a 5-for-1 stock split, while D.A. Davidson cut MongoDB’s target to $415 from $465 and JPMorgan cut Alnylam’s to $369 from $375.
1. Selected analyst actions
Oppenheimer adjusted its Carvana price target to $90 from $450 to reflect a 5-for-1 stock split. The roundup also listed Microsoft, where Piper Sandler raised its target to $610 from $550, and Lumentum, where Bernstein initiated coverage with an outperform rating and a $1,220 target.
2. Other target changes
D.A. Davidson cut its MongoDB target to $415 from $465; three other firms also lowered their MongoDB targets. The roundup included analyst rating and price-target changes for companies across multiple industries.
